Our purpose
Our mission is to develop biomarker driven technologies that bring tumor biology into platinum treatment decisions, improving the precision of cancer therapy.
Our Approach
At CHOSA, we develop gene expression–based biomarkers that identify patients most likely to benefit from platinum-based therapies. By integrating tumor biology into clinical decision-making, our technologies support more precise use of standard treatments.
Our Vision
We are working toward a a future where cancer treatment is guided by tumor biology, enabling therapies to be matched to the patients most likely to benefit.
-
We prioritize advancements that enhance response rates and minimize toxicity, improving both patient experience and outcomes.
-
We believe in a future where treatment is as unique as each patient, focusing on tailored solutions that are both safe and effective.
-
Our work is grounded in robust biological research and validated through rigorous scientific and clinical evaluation.
-
We are committed to improving how established cancer therapies are used, ensuring patients receive treatments most likely to benefit them.
We are driven by our core values
Meet the team advancing precision oncology
Our team is dedicated to advancing cancer care with compassion, innovation, and expertise. Each member of our team brings specialized knowledge and a shared commitment to improving patient outcomes and supporting our partners in oncology.
Achieving this vision requires collaboration across the oncology ecosystem.
We invite organizations across the oncology ecosystem , including pharmaceutical, diagnostic, and biosimilar innovators, to join us in advancing treatments guided by scientific evidence and a shared commitment to improving patient care.
(See the video for our perspective.)